151 related articles for article (PubMed ID: 11124964)
1. Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase: insights into kinase mechanism.
Till JH; Ablooglu AJ; Frankel M; Bishop SM; Kohanski RA; Hubbard SR
J Biol Chem; 2001 Mar; 276(13):10049-55. PubMed ID: 11124964
[TBL] [Abstract][Full Text] [Related]
2. Multiple activation loop conformations and their regulatory properties in the insulin receptor's kinase domain.
Ablooglu AJ; Frankel M; Rusinova E; Ross JB; Kohanski RA
J Biol Chem; 2001 Dec; 276(50):46933-40. PubMed ID: 11598120
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
[TBL] [Abstract][Full Text] [Related]
4. A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase.
Atwell S; Adams JM; Badger J; Buchanan MD; Feil IK; Froning KJ; Gao X; Hendle J; Keegan K; Leon BC; Müller-Dieckmann HJ; Nienaber VL; Noland BW; Post K; Rajashankar KR; Ramos A; Russell M; Burley SK; Buchanan SG
J Biol Chem; 2004 Dec; 279(53):55827-32. PubMed ID: 15507431
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of a cAMP-dependent protein kinase mutant at 1.26A: new insights into the catalytic mechanism.
Yang J; Ten Eyck LF; Xuong NH; Taylor SS
J Mol Biol; 2004 Feb; 336(2):473-87. PubMed ID: 14757059
[TBL] [Abstract][Full Text] [Related]
6. Electrostatic environment surrounding the activation loop phosphotyrosine in the oncoprotein v-Fps.
Leon BC; Tsigelny I; Adams JA
Biochemistry; 2001 Aug; 40(34):10078-86. PubMed ID: 11513586
[TBL] [Abstract][Full Text] [Related]
7. Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.
Lin L; Czerwinski R; Kelleher K; Siegel MM; Wu P; Kriz R; Aulabaugh A; Stahl M
Biochemistry; 2009 Mar; 48(9):2021-32. PubMed ID: 19206206
[TBL] [Abstract][Full Text] [Related]
8. Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family.
Artim SC; Mendrola JM; Lemmon MA
Biochem J; 2012 Dec; 448(2):213-20. PubMed ID: 22992069
[TBL] [Abstract][Full Text] [Related]
9. Global consequences of activation loop phosphorylation on protein kinase A.
Steichen JM; Iyer GH; Li S; Saldanha SA; Deal MS; Woods VL; Taylor SS
J Biol Chem; 2010 Feb; 285(6):3825-3832. PubMed ID: 19965870
[TBL] [Abstract][Full Text] [Related]
10. Unique activation mechanism of protein kinase CK2. The N-terminal segment is essential for constitutive activity of the catalytic subunit but not of the holoenzyme.
Sarno S; Ghisellini P; Pinna LA
J Biol Chem; 2002 Jun; 277(25):22509-14. PubMed ID: 11956194
[TBL] [Abstract][Full Text] [Related]
11. Identification of an autoinhibitory domain in the insulin receptor tyrosine kinase.
Filipek A; Soderling TR
Mol Cell Biochem; 1993 Mar; 120(2):103-10. PubMed ID: 8487750
[TBL] [Abstract][Full Text] [Related]
12. Structural characterizations of glycerol kinase: unraveling phosphorylation-induced long-range activation.
Yeh JI; Kettering R; Saxl R; Bourand A; Darbon E; Joly N; Briozzo P; Deutscher J
Biochemistry; 2009 Jan; 48(2):346-56. PubMed ID: 19102629
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic state.
Chatti K; Farrar WL; Duhé RJ
Biochemistry; 2004 Apr; 43(14):4272-83. PubMed ID: 15065871
[TBL] [Abstract][Full Text] [Related]
14. Intrasteric inhibition of ATP binding is not required to prevent unregulated autophosphorylation or signaling by the insulin receptor.
Frankel M; Ablooglu AJ; Leone JW; Rusinova E; Ross JB; Heinrikson RL; Kohanski RA
Mol Cell Biol; 2001 Jul; 21(13):4197-207. PubMed ID: 11390649
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based design of a protein kinase inhibitor.
Parang K; Till JH; Ablooglu AJ; Kohanski RA; Hubbard SR; Cole PA
Nat Struct Biol; 2001 Jan; 8(1):37-41. PubMed ID: 11135668
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of the Mnk2 kinase domain reveal an inhibitory conformation and a zinc binding site.
Jauch R; Jäkel S; Netter C; Schreiter K; Aicher B; Jäckle H; Wahl MC
Structure; 2005 Oct; 13(10):1559-68. PubMed ID: 16216586
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and X-ray crystallographic studies on shikimate kinase: the important structural role of the P-loop lysine.
Krell T; Maclean J; Boam DJ; Cooper A; Resmini M; Brocklehurst K; Kelly SM; Price NC; Lapthorn AJ; Coggins JR
Protein Sci; 2001 Jun; 10(6):1137-49. PubMed ID: 11369852
[TBL] [Abstract][Full Text] [Related]
18. Loop movement and catalysis in creatine kinase.
Wang PF; Flynn AJ; McLeish MJ; Kenyon GL
IUBMB Life; 2005; 57(4-5):355-62. PubMed ID: 16036620
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog.
Hubbard SR
EMBO J; 1997 Sep; 16(18):5572-81. PubMed ID: 9312016
[TBL] [Abstract][Full Text] [Related]
20. Structure and autoregulation of the insulin-like growth factor 1 receptor kinase.
Favelyukis S; Till JH; Hubbard SR; Miller WT
Nat Struct Biol; 2001 Dec; 8(12):1058-63. PubMed ID: 11694888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
